Grim statistics: Lung cancer is the leading cause of cancer death among men and women in the United States with more than 160,340 deaths a year, translating to 439 deaths a day, according to estimates of American Cancer Society.2 More than 50 percent of lung cancer is diagnosed in advanced stages and incurable, with five-year survival rate of less than 1 percent. However, early detection of lung cancer leads to longer survival and higher cure rate, with 92 percent five-year survival for Stage 1 disease.1
Recent advances: Recently, the National Lung Screening Trial (NLST) showed that low-dose CT scan (LDCT) screening modality decreases lung cancer mortality by 20 percent.3 This study demonstrated high sensitivity compared to conventional chest x-ray but has high false positive rates. This is the first time that a screening test showed decrease in mortality related to lung cancer.
Our care program: The University of Kansas Cancer Center has implemented a comprehensive lung cancer screening program. It includes smoking cessation counseling, multidisciplinary team with radiologist, pulmonologist, radiation oncologist, surgeon and medical oncology to manage and treat newly detected lung cancer and a nurse navigator to help coordinate the care of patients screened.
The lung cancer group is also developing a study to help increase the accuracy of LDCT. The study will incorporate the addition of a blood test currently available and also further genetic analysis to enhance the diagnostic precision of LDCT.
Lung Cancer Site Team's mission: "To provide exceptional clinical care with the latest advances in medical therapy and multidisciplinary approach; to advance the care of lung cancer patients through integration of clinical and basic science translational research; to educate the community by increasing awareness and knowledge of early detection and prevention; to accomplish these aspirations with the patient's well-being as the core of our mission by way of empathy and efficiency."
Other Lung Trials